First Quarter 2026 Financial Results April 30, 2026 © 2026 Alnylam Pharmaceuticals, Inc. 1 Agenda | 01 | Welcome | Christine Akinc Chief Corporate Communications Officer | | --- | --- | --- | | 02 | Overview | Yvonne Greenstreet, M.D. Chief Executive Officer | | 03 | Commercial Highlights | Tolga Tanguler Chief Commercial Officer | | 04 | Pipeline | Pushkal Garg, M.D. Chief Research & Development Officer | | 05 | Financial Summary | Jeff Poulton Chief Financial Officer | | 06 | Q&A Session | | Overview Yvon ...